Physician profile
Muhammad Moral
NPI 1528479722
$5,687.00
in general payments reported to CMS, 2019-2025
8 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2022: $5,239 · 2023: $21.21 · 2024: $174 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,794.99 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $2,444.21 | 2022 | |
| Smith+Nephew, INC. | $186.65 | 2024-2025 | N/A, Coblation |
| Medtronic USA, INC. | $101.29 | 2019 | |
| Gotham Surgical Solutions & Devices, INC. | $63.22 | 2024 | |
| Linvatec Corporation | $56.42 | 2024 | Biobrace 23mm |
| Stryker Corporation | $21.21 | 2023 | Hoffmann |
| Seapearl East, INC | $19.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Moral listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.